在大型医疗系统中用粪便免疫化学试验替代愈创木脂粪便隐血试验可提高筛查完成比例
在退伍军人事务部圣地亚哥医疗系统50-75岁接受粪便结直肠癌筛查的患者中,回顾性观察7898例,其中愈创木脂粪便隐血试验(gFOBT)3236例、粪便免疫化学试验(FIT)4662例。意向筛查分析显示FIT完成率42.6%高于gFOBT的33.4%(P < .001),FIT组检出进展期肿瘤比例0.79%高于gFOBT组的0.28%(P = .003)。作者认为所有医疗系统应强烈考虑用FIT替代gFOBT。
要点
- FIT完成率42.6%,高于gFOBT的33.4%(P < .001)。
- FIT组进展期肿瘤检出率0.79%,高于gFOBT组的0.28%(P = .003)。
- 每多邀请11人可多完成1例检测,每多邀请196人可多检出1例进展期肿瘤。
核心结论
- 在退伍军人事务部医疗系统的回顾性研究中,用FIT替代gFOBT提高了完成结直肠癌筛查的患者比例。
- 作者认为所有医疗系统应强烈考虑用FIT替代gFOBT。
研究设计与样本
- 回顾性观察研究,纳入退伍军人事务部圣地亚哥医疗系统50-75岁、2014年3月至2015年1月期间作为初级保健一部分接受粪便结直肠癌筛查的患者7898例。
- 主要结局为医嘱后1年内完成检测;次要结局为阳性结果及诊断性结肠镜检出进展期肿瘤。
- 主要分析采用意向筛查方法,纳入所有有检测医嘱的患者,并进行了按实际筛查分析。
主要发现
- 7898例患者中,gFOBT医嘱3236例,FIT医嘱4662例。
- 意向筛查分析中,FIT完成率42.6%,高于gFOBT的33.4%(P < .001)。
- FIT组进展期肿瘤检出率0.79%,高于gFOBT组的0.28%(P = .003)。
- 每多邀请11人可多完成1例检测,每多邀请196人可多检出1例进展期肿瘤。
临床怎么用
- 作者认为所有医疗系统应强烈考虑用FIT替代gFOBT。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The most commonly used noninvasive test for colorectal cancer (CRC) screening has been the guaiac fecal occult blood test (gFOBT). The fecal immunochemical test (FIT) detects CRC and colorectal polyps with higher levels of sensitivity than the gFOBT, and may be more acceptable to patients. However, the FIT has not replaced the gFOBT in many clinical settings. We analyzed data from a large healthcare system that replaced the gFOBT with the FIT to determine the effects on CRC screening. METHODS: We conducted a retrospective observational study of 7898 patients at the Veterans' Administration San Diego Healthcare System, 50-75 years old, who were offered stool-based CRC screening as part of primary care March 2014 through January 2015. Test orders and results were extracted from electronic health records; we performed manual reviews of colonoscopy and pathology reports for Veterans with positive results from the tests. Our primary outcome was test completion within 1 year of order; secondary outcomes were positive results and detection of advanced neoplasia by diagnostic colonoscopy. The primary analysis used an intention-to-screen approach, which included all patients with test orders; as-screened analyses were also performed. RESULTS: Among 7898 patients, 3236 had gFOBT and 4662 FIT orders. In the intention to screen analysis, a significantly higher proportion of subjects completed a FIT (42.6%) than a gFOBT (33.4%) (P < .001); advanced neoplasia was detected in a significantly higher proportion of subjects offered a FIT (0.79%) than a gFOBT (0.28%) (P = .003). The numbers needed to invite to achieve 1 additional completed test and identify 1 additional patient with advanced neoplasia were 11 and 196, respectively. CONCLUSIONS: In a retrospective study of patients at a Veterans' administration healthcare system, replacing the gFOBT with the FIT increased the proportion of patients who completed CRC screening. Replacement of the gFOBT with the FIT should be strongly considered by all healthcare systems.
引用
- Akram A, Juang D, Bustamante R, et al. Replacing the Guaiac Fecal Occult Blood Test With the Fecal Immunochemical Test Increases Proportion of Individuals Screened in a Large Healthcare Setting. Clin Gastroenterol Hepatol. 2017. PMID: 28167157. doi:10.1016/j.cgh.2017.01.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。